Moderna and vertex establish new collaboration to treat cystic fibrosis using gene editing

Moderna and vertex establish new collaboration to treat cystic fibrosis using gene editing.moderna inc - second collaboration between moderna and vertex based on moderna's proprietary mrna and lnp technology.moderna inc - moderna to receive $75 million upfront, with potential for additional development, regulatory and commercial milestones and royalty payments.moderna inc - eligible to receive up to $380 million in development, regulatory and commercial milestones, plus royalties from collaboration with vertex.moderna - three-year research collaboration with vertex initially to focus on discovery and optimization of novel lnps and mrnas.
VRTX Ratings Summary
VRTX Quant Ranking